نتایج جستجو برای: platelet counts

تعداد نتایج: 165352  

2014
Liu Huang Fengju Chen Yangyang Chen Xiaomei Yang Sanpeng Xu Shuwang Ge Shengling Fu Tengfei Chao Qianqian Yu Xin Liao Guangyuan Hu Peng Zhang Xianglin Yuan

The predictive value of thymidine phosphorylase gene variants (TP, also called platelet-derived endothelial cell growth factor) and thrombocytosis were controversial and worthy of further study in gastrointestinal cancer (GIC) patients. We screened all of the common missense single nucleotide polymorphisms (MAF ≥ 0.1) in fluoropyrimidines (FU) pathway genes (including TP, TS, ENOSF1 and DPD). T...

2014
Lenar Yessayan Jerry Yee Gary Zasuwa Stan Frinak Anatole Besarab

BACKGROUND Iron deficiency is common in non-dialysis chronic kidney disease (ND-CKD) patients and, on occasion, requires parenteral iron therapy. We investigated the effect of intravenous iron repletion on platelet counts in ND-CKD patients with and without concomitant darbepoetin administration. METHODS We conducted a retrospective analysis of ND-CKD patients with iron deficiency anemia trea...

Journal: :Cancer research 1973
S Berger L M Aledort H S Gilbert J P Hanson L R Wasserman

with varying platelet counts. Adenosine diphosphate, epinephrine, collagen, and thrombin were used as aggregating agents. Eighty-one % of the 62 studies were abnormal. The frequency of abnormal tests increased from those with normal hematocrits and platelet counts (75%) through to those with elevated hematocrits and platelet counts (100%). One hundred % of the studies in spent polycythemia vera...

Journal: :British medical journal 1983
A D Harries E Fitzsimons R Fifield M J Dew J Rhoades

Platelet count: a simple measure of activity in Crohn's disease Thrombocytosis may occur in inflammatory bowel disease and probably represents a non-specific response to inflammation.1 2 We have observed raised platelet counts in patients with active Crohn's disease, and we therefore investigated whether the platelet count is a useful index of disease activity. We studied 57 patients with Crohn...

Journal: :international journal of hematology-oncology and stem cell research 0
mehrzad mirzania imam khomini hospital complex, vali-e-asr hospital, tehran university of medical sciences, tehran, iran. sedigheh khalili arak university of medical sciences, arak, iran. akbar hasanpoor arak university of medical sciences, arak, iran. ahmad reza shamshiri hematology-oncology and stem cell research center, tehran university of medical sciences, tehran, iran.

amegakaryocytic thrombocytopenia (amt) is a rare cause of acquired thrombocytopenia. the pathogenesis and treatment of amt is not clearly known. here we demonstrate a 50-year-old man presented with the clinical manifestations of severe thrombocytopenia (7000 platelets/µl) with a marked decrease to absent of megakaryocytes in the bone marrow. the patient did not respond to intravenous immunoglob...

2014
Alice Assinger

Platelets are anucleate blood cells that play a crucial role in the maintenance of hemostasis. While platelet activation and elevated platelet counts (thrombocytosis) are associated with increased risk of thrombotic complications, low platelet counts (thrombocytopenia) and several platelet function disorders increase the risk of bleeding. Over the last years, more and more evidence has emerged ...

Journal: :The New England journal of medicine 2006
James B Bussel David J Kuter James N George Robert McMillan Louis M Aledort George T Conklin Alan E Lichtin Roger M Lyons Jorge Nieva Jeffrey S Wasser Israel Wiznitzer Reggie Kelly Chien-Feng Chen Janet L Nichol

BACKGROUND Most current treatments for chronic immune thrombocytopenic purpura (ITP) act by decreasing platelet destruction. In a phase 1-2 study, we administered a thrombopoiesis-stimulating protein, AMG 531, to patients with ITP. METHODS In phase 1, 24 patients who had received at least one treatment for ITP were assigned to escalating-dose cohorts of 4 patients each and given two identical...

Journal: :Lancet 2008
David J Kuter James B Bussel Roger M Lyons Vinod Pullarkat Terry B Gernsheimer Francis M Senecal Louis M Aledort James N George Craig M Kessler Miguel A Sanz Howard A Liebman Frank T Slovick J Th M de Wolf Emmanuelle Bourgeois Troy H Guthrie Adrian Newland Jeffrey S Wasser Solomon I Hamburg Carlos Grande François Lefrère Alan Eli Lichtin Michael D Tarantino Howard R Terebelo Jean-François Viallard Francis J Cuevas Ronald S Go David H Henry Robert L Redner Lawrence Rice Martin R Schipperus D Matthew Guo Janet L Nichol

BACKGROUND Chronic immune thrombocytopenic purpura (ITP) is characterised by accelerated platelet destruction and decreased platelet production. Short-term administration of the thrombopoiesis-stimulating protein, romiplostim, has been shown to increase platelet counts in most patients with chronic ITP. We assessed the long-term administration of romiplostim in splenectomised and non-splenectom...

Journal: :American journal of hematology 2005
A Keidar M Feldman A Szold

Laparoscopic splenectomy (LS) is now performed routinely in patients with idiopathic thrombocytopenic purpura (ITP) refractory to the medical treatment. Low preoperative platelet count was deemed to be a contraindication for a laparoscopic approach; however, there is no data reporting the outcome in those patients. We aimed to evaluate the influence of the preoperative platelet count on the ope...

Journal: :Blood 1998
H M Rinder J E Schuster C S Rinder C Wang H J Schweidler B R Smith

There are no readily applicable methods to routinely assess thrombosis risk and treatment response in thrombocytosis. Reticulated platelets (RP) define the most recently released platelets in the circulation, and the RP% has been shown to estimate platelet turnover in thrombocytopenic states. We examined whether increased RP values were associated with thrombotic complications in thrombocytosis...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید